Physician profile
Joseph Sidari
NPI 1699709584
$3,183.75
in general payments reported to CMS, 2019-2025
22 companies · $157 in 2025
The $157 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $463 · 2020: $1,977 · 2021: $16.25 · 2022: $84.90 · 2023: $267 · 2024: $218 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $507 · Consulting Fee: $135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $507.25 |
| Consulting Fee | $135.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $1,760.00 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $337.58 | 2019-2025 | Enhertu, Imfinzi |
| Medtronic USA, INC. | $150.00 | 2020 | |
| Seagen INC. | $144.83 | 2022-2023 | Padcev |
| Medtronic, INC. | $135.00 | 2023 | Skeeter, Merocel |
| E.R. Squibb & Sons, L.L.C. | $126.25 | 2019-2020 | |
| Glaxosmithkline, LLC. | $90.18 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $58.42 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $55.70 | 2019-2023 | Dupixent |
| Optinose US, INC. | $40.80 | 2019 | |
| Acclarent, INC | $32.32 | 2019 | |
| Genzyme Corporation | $30.71 | 2024 | |
| Karyopharm Therapeutics INC. | $28.57 | 2025 | Xpovio |
| Smith+Nephew, INC. | $26.75 | 2019 | |
| Servier Pharmaceuticals LLC | $24.98 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $24.98 | 2024 | |
| Merck Sharp & Dohme LLC | $24.02 | 2023 | Keytruda |
| Freudenberg Medical, LLC | $23.54 | 2024 | |
| Novartis Pharmaceuticals Corporation | $22.08 | 2019 | |
| Intersect Ent, INC. | $18.52 | 2019 | |
| Stryker Corporation | $16.25 | 2021 | |
| Ambu INC. | $12.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Sidari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.